Funded by the Marie Skłodowska-Curie Actions, H2020
As a result of expanding efforts to improve cancer therapy, a main paradigm change has occurred by targeting the immune system, not the tumor itself. "Science" highlighted immunotherapy of cancer as "breakthrough of the year 2013". Antibody-based therapies form an integral and constantly growing part of this approach leading towards individualised medicine. These therapies will strongly influence the coming decade of cancer care.
The training network for the immunotherapy of cancer (IMMUTRAIN), received 3,6 Mio.€ for four years from the European Union in order to perform cutting-edge research in this field and to respond to the increasing demand for well-trained and skilled researchers. The network is coordinated by Prof. Dr. Stefan Endres and PD Dr. Sebastian Kobold from the Division of Clinical Pharmacology at the Ludwig-Maximilians-Universität München. IMMUTRAIN will bring together experts of nine European countries in the fields of monoclonal antibodies, dendritic cells, T-cells and immunomodulatory nucleic acids. The network also offers a considerable industrial involvement to train the next generation of scientists from different perspectives and give insights in different research environments.
Young researchers recruited by IMMUTRAIN will benefit from a network comprising nine academic research groups and five industrial partners. The network will actively create synergies between those sectors by forming and promoting young researchers to match the challenges of immunotherapies.
Training programme and scientific projects
The overall scientific objective of IMMUTRAIN is to enhance the efficacy of antibody-based therapies through combination with other immunotherapeutic approaches. Each early stage researcher (ESR) will be appointed for a scientific project by a partner of the network (host institution) and supervised by one or more senior scientists (PI). Each project is part of one of the four scientific work packages of IMMUTRAIN.
IMMUTRAIN’s training objectives are: 1) To give an extensive overview of immunologic combination partners for antibodies. 2) To teach how to develop new therapies (target validation, drug discovery and development). 3) To provide a broad methodological know-how in the field of immunotherapy. 4) To provide transferable skills. 5) To give an insight into the respective chances and challenges of the academic and industrial sectors. 6) To provide academic and industry contacts for later cooperations and/or employment.
Call for applications
The IMMUTRAIN program is looking for Early Stage Researchers (ESR) to join the training and research program. IMMUTRAIN offers a three years training program in the immunotherapy of cancer with the possibility of earning a doctoral degree (PhD or equivalent).
Two positions are open:
ESR 1 and ESR 13
Further information: www.immutrain.eu
We offer :
- Cutting-edge-research projects
- State-of-the-art and innovative international training in one of the most exiting fields of biomedical research: cancer immunotherapy
- Projects with strong translational perspective
- The possibility to obtain a doctoral degree
- Excellent training and opportunities for future employment in academic and private sector
- An employment contract for three years with all the benefits of the Marie Skłodowska-Curie programme:
- a living allowance (salary including e.g. social security)
- a mobility allowance
- a family allowance (if applicable).
- The application procedure will be carried out in compliance with the Code of Conduct for Recruitment and the Charter for Researchers
- Excellent scientists with a master degree or equivalent in natural sciences or related disciplines (such as medicine or pharmacy)
- Practical skills in modern laboratory work, preferentially combined with experience in animal experiments
- Be within your first four years of research experience after completion of your masters degree or equivalent
- Not have spent more than 12 months within the past 36 months in the country where the institution you are applying for is located (mobility rule)
- Not hold a doctoral degree at the time of recruitment
- Be proficient in the English language both written and spoken (proof required)
Please note that we will require the strict application of any of the "must" criteria prior to recruitment. If you fail to provide firm evidence for any of these criteria, you will be excluded from further consideration for the program.
For any questions or inquiries, please contact Simone Gautier, Division of Clinical Pharmacology, Klinikum der Universität München
Welcome to our application site
The application form contains nine different tabs enabling you to enter all required information and to upload corresponding documents. To save entries please click the Save Button at the bottom of the page. Entries will not be saved automatically. You may revisit and modify your personal application form any time prior to final submission. When you are ready to submit your application, please click the Save and Submit Button. After submission you will no longer be able to edit your application. However, you will be able to view your submitted data throughout the application process. Submission of applications is only possible, if all required fields (marked with a yellow triangle) are filled out. Non required fields are optional but it is recommended to fill out all those fields that apply to your specific situation.
Two letters of recommendation are required for the application. Please contact as soon as possible persons who know your academic and scientific performance (professors, trainee supervisors...). This will allow your mentors sufficient time to submit the letters in a timely manner. Please remind to indicate the e-mail address of your mentors as referees in the field "References".
We only accept non-encrypted PDF files (recommended) or JPEG files. Uploads have a size restriction of 5 MB each. It is recommended to scan documents with 300dpi. If a document consists of more than one page please combine those pages into a single PDF document. IMPORTANT: Please make sure that your documents are NOT password protected or encrypted. Encrypted files can not be processed and hence will not be available to members of the admissions committee.
If you click on My Progress in the left menu, you will be able to see the current status of your application.
Your application file
To view the final pdf file of your application please click on the tab "PDF", choose a template from the list and click on Download PDF. A pdf file will then be generated that is identical to the one, seen by the admissions committee (except the confidential letters of reference that will not be displayed in your version). Some of the fields you have filled out will not be displayed in this document (but will be stored in our data bank).
The deadline for submission of applications is extended to September 9th, 2016. All applications having been submitted until the deadline will be evaluated.